甲氨蝶呤、阿糖胞苷、塞替哌联合利妥昔单抗（MATRix方案）治疗初治原发中枢神经系统淋巴瘤的疗效分析
Chemoimmunotherapy with Methotrexate, Cytarabine, Thiotepa, and Rituximab （MATRix Regimen） in Patients with Primary Central Nervous System Lymphoma
甲氨蝶呤、阿糖胞苷、塞替哌联合利妥昔单抗（MATRix方案）治疗初治原发中枢神经系统淋巴瘤的疗效分析 |
| 评价者：李维, 张会来 |
Chemoimmunotherapy with Methotrexate, Cytarabine, Thiotepa, and Rituximab （MATRix Regimen） in Patients with Primary Central Nervous System Lymphoma |
| |